Second-generation Zika vaccine (Institut Pasteur)

N/A

Report date: 2024/07/26 14:52:55

Base Information

Drug NameSecond-generation Zika vaccine (Institut Pasteur)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsZika Virus Infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesInstitut Pasteur

China Registration ClassN/A

Develop Information

Active CompaniesThemis Bioscience Gmbh

Inactive CompaniesN/A

Active IndicationsZika Virus Infection

Inactive IndicationsN/A

Other Information

ATC CodeN/A